City
Epaper

Indonesia's 3rd Covid wave expected to peak in mid-Feb

By IANS | Published: January 14, 2022 1:27 PM

Jakarta, Jan 14 The peak of the third Covid-19 wave in Indonesia triggered by the Omicron variant is ...

Open in App

Jakarta, Jan 14 The peak of the third Covid-19 wave in Indonesia triggered by the Omicron variant is expected to occur in mid-February, the Health Ministry said.

The peak will probably happen in the second or third week of February, with daily cases up to 40,000 to 55,000, spokesperson for the Health Ministry's Covid-19 vaccination program Siti Nadia Tarmizi said.

Till date, the country has recorded 506 Omicron cases, including 84 local transmissions, as well as 1,384 probable cases of the variant based on the S-gene target failure (SGTF) swab test method.

Thousands of probable Omicron cases are currently in the process of whole genome sequencing, Tarmizi said, adding that the daily number of Covis-19 cases in the country continues to rise with the total tally at 4,268,890.

Indonesia has managed to cope with the second wave of transmissions of the Delta variant, which saw a peak of 56,757 cases on July 15, 2021.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: JakartaindonesiaHealth Ministry
Open in App

Related Stories

InternationalIndonesia: 6.5-Magnitude Earthquake Hits, No Tsunami Alert Issued

InternationalIndonesia Officially Declares Prabowo Subianto as President Following Electoral Dispute

InternationalIndonesia: International Air Travel Disrupted in the Region Due to Volcanic Eruption in North Sulawesi, More Than 11000 People Evacuated

InternationalIndonesia Issues Tsunami Warning After More Eruption From Mount Ruang (Watch Video)

InternationalTsunami Alert in Indonesia: Thousands Evacuated After Volcano Erupts At Ruang Mountains

Health Realted Stories

HealthKnow Why Chia Seeds Are a Powerful Addition to Your Diet

HealthTB claimed 108 lives in Mizoram in 2023

HealthReducing air pollution key to fight new diabetes cases in India: Doctors

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

HealthCovaxin has excellent safety record, says Bharat Biotech